Post-approval studies (Phase 4)Ended earlyNCT04381494
What this trial is testing
Mobile Devices to Detect Early Pneumonitis in Stage III NSCLC Patients on Durvalumab.
Who this might be right for
Unresectable Stage III NSCLC
AstraZeneca 40
Showing 20 of 0 results